Key Takeaways
- Revenue surged, margins compressed: Consolidated Q4 revenue grew to INR102.3 crores from INR38.7 crores YoY, but gross margin fell to 49.9% for FY24 from 68.4% in FY23, driven by aggressive contract pricing and import costs.
- US market entry is deliberate, not rushed: Beta testing with law enforcement is underway, with early sales expected this year; management is prioritizing product-market fit over speed to avoid expectation mismatches.
- Order book provides near-term visibility: A INR125 crore order book plus a INR300 crore L1 pipeline expected to convert in one to two quarters supports the growth plan, though formal FY25 guidance is withheld.
- Investment cycle is compressing margins: Higher employee costs from ESOP provisions, development capitalization that will increase amortization, and strategic ecosystem investments are creating EBITDA variability that management frames as growth investment.
- What to watch next quarter: Whether the INR300 crore L1 pipeline converts on schedule, the pace of US early sales, and whether gross margins stabilize as development investments are recouped on mature products.
Revenue Growth & Order Book
- Quarterly surge: Q4 revenue hit INR102.3 crores, up from INR38.7 crores YoY, bringing full-year FY24 revenue to INR314 crores from INR186 crores, in line with the plan to grow substantially.
- Order book visibility: The existing order book of INR125 crores is expected to execute within the first couple of quarters; some orders added within a quarter get executed in the same quarter due to good execution pace.
- L1 pipeline: A INR300 crore pipeline of L1 opportunities is expected to convert in the next one to two quarters, with healthy additions expected from the international market early in the year.
- Growth without guidance: Management plans to grow in FY25 but is holding back on formal guidance, and declined to put a number on a three-year revenue aspiration when asked about a potential INR1000 crore target.
- Quarterly variability warning: Management cautioned that quarterly comparisons do not provide the full picture; the right way to assess the business includes technology development, business diversification, and overall strategy.
Ankit Mehta: "We definitely have very high aspirations, Deepak. However, I don't want to put a number on that aspiration presently."
Margin Structure & Cost Pressures
- Gross margin compression: Gross profit margin fell to 49.9% in FY24 from 68.4% in FY23, a function of particular contracts where the company bid aggressively, either for advanced technology or against competing specifications.
- Import cost burden: Imports stood at close to 20% of operating revenue for FY24, contributing to margin pressure, though the indigenization strategy is progressively mitigating input material costs.
- Employee cost spike: Q4 saw a spike from ESOP and bonus provisions, though overall annual employee cost was flat YoY; ballpark numbers are expected to stay in the same range going forward.
- Development amortization rising: INR38 crores was capitalized in FY24 out of INR47 crores total under development, amortized over three years; the INR12 crore amortization impact will increase as other projects mature.
- Contribution margin variability: Management attributed the three-year decline in contribution margin from 74% to 49% to particular contract choices and investment in future growth, noting that EBITDA percentage varies less than gross margin because some products have recouped their development investments.
- PLI is additive, not structural: The 12% PLI is included in Q4 revenue and contributes to profitability, but management stated the company is profitable without it and does not depend on it as a necessary crutch.
Ankit Mehta: "it does not imply that we are not profitable without it as well. Therefore, these are not necessary crutches for us to generate profits."
US Market Strategy
- Beta testing underway: UAVs have been deployed with law enforcement agencies for beta testing, with real-life missions delivering a differentiated experience versus existing inventory.
- Deliberate pace: Management is not rushing to sales, believing that a new market requires understanding the customer better first; pushing sales risks expectation mismatches on software features or user experiences carried over from other products.
- Early vectors identified: Public safety, law enforcement, and enterprise use cases are likely to be the early adoption vectors; defense will take more time due to the procurement learning curve.
- Sales timeline: Early sales are expected this year, with aggressive sales pursuit from next quarter onwards; healthy contribution is expected in FY25-FY26.
Ankit Mehta: "we were not rushing to the products sale because we believe that it's a new market and we need to know the customer a little bit better before we go and sell because a lot of times products don't do well when we try to push sales and the expectation mismatch in terms of not necessarily in terms of performance and reliability, but in terms of certain small features on software or certain experiences that they have from other products are not replicated on the new product that they're trying out."
Product Development Pipeline
- Tactical UAV: Flight trials of early builds have been initiated, marking progress on a new platform category.
- Middle-mile logistics UAV: Significant progress has been made on operational envelope definition, moving toward configuration finalization; the plan is to get an early prototype flying this year, though the company is taking more time for simulation and analysis given the platform size and challenging environment ambition.
- Technology development breadth: Six patents were granted in Q4, bringing the total to 38 out of 72; developmental efforts are upgrading quadcopter and hybrid VTOL platforms with features including swarming and GPS-denied environment operations.
- Open platform play: The company is opening a drone platform for ecosystem innovation, partnering with others to build specialized payloads like fog-penetration and foliage-penetration radars, and enabling analytics players to build on collected data.
Ankit Mehta: "we've invested a lot of time in simulation and analysis. We have investigated the best possible configuration that we can offer for this technology, given what physics will let us."
Indigenization & Ecosystem Investments
- Nautical Wings investment: The company invested in Nautical Wings, a downstream supplier with differentiated subsystem capability, to increase indigenous content and de-risk domestic drone production from global geopolitics; subsystems have already been adopted in ideaForge production.
- Indigenization progress: The strategy is delivering positive outcomes on both cost of input materials and indigenization percentage, progressively mitigating cost as a factor in operational efficiency.
- Ecosystem budget: Management intends to keep funds available for similar investments, with budgets allocated and eyes open for opportunities.
- Certification milestone: AS9100D and ISO 9001:2015 certification was obtained from TÜV SÜD, considered the gold standard in the aerospace industry.
Ankit Mehta: "we thought that if we can support the ability to build technology, not just at the system level, but also at the subsystem level in the country, we will see greater indigenization de-risking of the overall country's ability to produce drones from global geopolitics."
Drone-as-a-Service & New Business Models
- DaaS pilot progress: Pilot programs with anchor customers have yielded encouraging results, laying the groundwork for commercialization at scale.
- Franchisee model ambition: The next goal is to evolve from Company-Owned, Company-Operated to a Franchisee-Owned, Franchisee-Operated business, though no timeline was given.
- R&D talent build: The company onboarded substantial high-quality talent at all levels, including top university graduates, lateral hires, and leadership across hardware, software, and experience design.
- Partnership ecosystem: Collaborations with ESRI and GalaxEye are underway for joint solution development and go-to-market strategies.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| L1 pipeline conversion | INR300 crore L1 pipeline expected to convert to orders | Next one to two quarters |
| US early sales | First sales expected; aggressive chase from next quarter | This year, with healthy contribution in FY25-FY26 |
| Middle-mile prototype | Early prototype to be flying | This year |
| Order book execution | Existing INR125 crore order book to be executed | First couple of quarters |
| Employee cost range | Ballpark numbers to stay in same range | Going ahead |
| No large capex | Apart from development expenditures continuing as product portfolio grows | Ongoing |
Key Metrics
| Metric | Q4 FY24 |
|---|---|
| Revenue | ₹102.3 cr, versus ₹38.7 cr in Q4 FY23 |
| Gross profit | ₹44 cr, gross margin of 43% |
| EBITDA | ₹20.2 cr, versus ₹5.4 cr in Q4 FY23; EBITDA margin 19.8% |
| PAT | ₹10.3 cr, versus negative ₹5.4 cr in Q4 FY23; PAT margin 10.1% |
| FY24 revenue | ₹314 cr, versus ₹186 cr in FY23 |
| FY24 gross margin | 49.9%, versus 68.4% in FY23 |
| FY24 EBITDA margin | 27.4%, versus 30.9% in FY23 |
| FY24 PAT margin | 14.4%, versus 17.2% in FY23 |
| Order book | ~₹125 cr as of March 31 |
| L1 pipeline | ₹300+ cr |
| Basic EPS (FY24) | 10.96; diluted EPS 10.77 |
| R&D expenditure (FY24) | ~₹51 cr, with ~₹25 cr capitalized |
| R&D team strength | ~200 people, added 84 over the year |
| Cumulative customer flights | >450,000 |
| Total granted patents | 38 out of 72 total (granted plus pending) |